We have investigated aspects of thymidine metabolism and function in cultured mammalian cells infected with herpes simplex virus under conditions in which virus DNA synthesis was either permitted, or was prevented by inhibiting the virus-induced DNA polymerase with phosphonoacetate. In 30 min pulse-labelling experiments the rates of [3H]thymidine transport into cells and its subsequent phosphorylation both reached maximum values about 6 h after infection. During the next 17 h these rates remained relatively constant in the absence of phosphonoacetate but declined to about 50% of the 6 h value in the presence of this inhibitor. When the radioactive thymidine was present continuously throughout the infection the accumulated intracellular acid-soluble radioactivity reached maximum values at about 9 h. In the absence of phosphonoacetate this declined thereafter, but it remained relatively constant when virus DNA synthesis was prevented. This suggests some established equilibrium between the continuing entry of thymidine into cells and its subsequent removal by excretion. Excretion of thymidine-derived radioactivity was initially established by determining the fate of isotopically labelled host cell DNA. During 24 h of infection about 50% of the host cell DNA was rendered acid-soluble and of this 60 to 70% was excreted from the cells. High pressure liquid chromatographic analysis of the intracellular acid-soluble radioactivity showed only phosphorylated thymidine derivatives, whereas the excreted radioactivity was exclusively in thymidine. Excretion of intracellular radioactive molecules derived directly from [3H]thymidine in the medium was also observed, but only when virus DNA synthesis was inhibited with phosphonoacetate.
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SUMMARY
We have investigated aspects of thymidine metabolism and function in cultured mammalian cells infected with herpes simplex virus under conditions in which virus DNA synthesis was either permitted, or was prevented by inhibiting the virus-induced DNA polymerase with phosphonoacetate. In 30 min pulse-labelling experiments the rates of [3H]thymidine transport into cells and its subsequent phosphorylation both reached maximum values about 6 h after infection. During the next 17 h these rates remained relatively constant in the absence of phosphonoacetate but declined to about 50% of the 6 h value in the presence of this inhibitor. When the radioactive thymidine was present continuously throughout the infection the accumulated intracellular acid-soluble radioactivity reached maximum values at about 9 h. In the absence of phosphonoacetate this declined thereafter, but it remained relatively constant when virus DNA synthesis was prevented. This suggests some established equilibrium between the continuing entry of thymidine into cells and its subsequent removal by excretion. Excretion of thymidine-derived radioactivity was initially established by determining the fate of isotopically labelled host cell DNA. During 24 h of infection about 50% of the host cell DNA was rendered acid-soluble and of this 60 to 70% was excreted from the cells. High pressure liquid chromatographic analysis of the intracellular acid-soluble radioactivity showed only phosphorylated thymidine derivatives, whereas the excreted radioactivity was exclusively in thymidine. Excretion of intracellular radioactive molecules derived directly from [3H]thymidine in the medium was also observed, but only when virus DNA synthesis was inhibited with phosphonoacetate.
Simple kinetic studies with the purified virus-induced DNA polymerase showed that a straight line double-reciprocal plot was obtained when dGTP was used as the limiting substrate (Km = 0.8 aM, Vmax = 330 nmol dGTP incorporated/10 min) but that a biphasic plot was obtained when dTTP was limiting (Kml ---- 0.5 aM, Vmaxl = 208 nmol dTTP incorporated/10 min; Kin2 = 5 aM, Vmax2 = 370 nmol dTTP incorporated/10 rain).
INTRODUCTION
Infection of mammalian cells with herpes simplex virus type 1 (HSV-1) results in the induction in activity of a number of enzymes involved in DNA synthesis and DNA precursor metabolism. These include a new virus-coded DNA-dependent DNA polymerase, first observed by Keir & Gold (1963) , a deoxypyrimidine kinase, with both thymidine and deoxycytidine kinase activities (Jamieson et al., 1974) , an alkaline deoxyribonuclease 0022-1317/82/0000-4889 $02.00 © 1982 SGM H. N. BAYBUTT, B. A. MURRAY AND C. K. PEARSON (Morrison & Keir, 1968) , deoxycytidine deaminase (Chan, 1977) , CDP-reductase (Cohen, 1972) and possibly dCMP deaminase (Rolton & Keir, 1974) , although other workers have not been able to demonstrate induction of this enzyme in herpesvirus-infected cells (Langelier et al., 1978; Huszar & Bacchetti, 1981) . Concomitant with the induction of these enzyme activities, in particular the deoxypyrimidine kinase, exogenous thymidine is taken up into the cell and is rapidly phosphorylated before being incorporated into DNA (Jamieson & Bjursell, 1976 a: Bittlingmaier et al., 1977 .
The activity of many of the cell enzymes involved in DNA precursor metabolism appears to be controlled by deoxyribonucleoside triphosphate (Koerner, 1970) , whereas some of the key enzymes induced after herpesvirus infection, such as thymidine kinase and ribonucleotide reductase, are refractory to inhibition by dTTP (see Ponce de Leon et al., 1977) . These workers drew attention to the possibility that the induction by HSV of a new set of enzymes, which are refractory to the inhibitory role exerted by dTTP, may free the virus from normal cellular controls, but would allow pyrimidine synthesis to continue in cells that have shut down their machinery for synthesizing DNA. The major change in precursor pool concentration after herpesvirus infection is that of dTTP, which increases some 25-to 50-fold (Jamieson & Bjursell, 1976a) , possibly as a result of both the induced thymidine kinase activity and the activation and/or new synthesis of thymidine transport sites (Bittlingmaier et al., 1977) . The thymidine nucleotides then represent some 85% of the deoxyribonucleoside triphosphate complement. This is interesting in view of the fact that the G + C content of HSV DNA is some 67% and supports proposals for a role for dTTP other than simply that as a precursor of DNA. The detailed studies of Jamieson & Bjursell (1976 a, b) have provided a considerable body of information concerning the deoxyribonucleotide pool sizes in herpesvirus cells and have emphasized a central role for dTTP in cellular processes, in that it can act as a positive effector for the production of dGTP and dATP, whilst at higher concentrations it may inhibit dATP production; in addition, there appears to be a lower limit to the dTTP pool size below which DNA synthesis does not occur.
In view of this established importance of thymidine metabolites we have extended these studies and describe in this paper aspects of thymidine metabolism when DNA synthesis is prevented, and simple kinetic studies which indicate that dTTP may act as a regulator of the herpesvirus-induced DNA polymerase in addition to being a substrate for DNA synthesis. The inhibitor of the HSV-1-induced DNA polymerase, phosphonoacetate (Mao et al., 1975) , was used to inhibit virus DNA synthesis, whilst host-cell DNA synthesis was inhibited by treating cells before infection with 5-fluorouracil (Kaplan & Ben-Porat, 1964) .
METHODS
Cell cultures.
Baby hamster kidney cells, BHK-21/C13 (Macpherson & Stoker, 1962) , were routinely grown in monolayer culture at 37 °C under 5 % CO2/air in Eagle's medium (Glasgow modification) containing 10% (v/v) calf serum and 10% (v/v)tryptose phosphate broth (ETC lo). The cells were free from mycoplasma or bacterial infection.
Inhibition of host cell DNA synthesis and subsequent injection oj cells with virus. Cultures of confluent BHK-21/C 13 cell monolayers were incubated for 16 h in 5-FU medium [Earle's saline containing 0.5% (w/v) lactalbumin hydrolysate, 5% (v/v) calf serum and 5-fluorouracil (5-FU) at 20 #g/ml] to arrest host cell DNA synthesis before virus infection (Kaplan & Ben-Porat, 1964 and then harvested after first washing three times in ice-cold phosphate-buffered saline (PBS) [0.14 % (w/v) Na2HPO 4, 0.03 % (w/v) KH2PO4, 0.03 % (w/v) KC1 and 1% (w/v) NaC1 pH 7.2]. Cells were precipitated with 0.1 M-perchloric acid and the precipitate, containing 3H-labelled DNA, was collected and resuspended in 0.5 ml 0.5 M-NaOH; samples were spotted on to GF/C filter discs and counted for radioactivity (Pearson et al., 1976) . The supernatant which remained after removal, by centrifugation, of the perchloric acidprecipitable material was neutralized by adding about 0.1 ml 0.72 M-KOH containing 0.6 M-KHCO 3. The precipitated potassium perchlorate was removed by centrifugation and portions of the supernatant spotted on to DEAE-cellulose paper discs (DE-81 paper, Whatman) which were then counted for radioactivity in a toluene-based scintillation fluid. This provided a measure of total acid-soluble radioactivity.
To measure the extent of thymidine phosphorylation, portions of the neutralized supernatant were spotted on to DE-81 discs, as described above, but the discs were then washed three times in 1 mM-ammonium formate buffer pH 3.6 twice in water and twice in 95% ethanol before drying and counting for radioactivity (Kucera & Edwards, 1979) . Control experiments showed that thymidine was completely removed by this simple procedure but phosphorylated derivatives were quantitatively retained. Chromatographic analysis on DE-81 paper confirmed that radioactive molecules binding to the paper were phosphorylated thymidine derivatives. Intracellular acid-soluble samples were obtained as described above. That is, after precipitating cellular macromolecules with perchloric acid the perchlorate was subsequently removed from the supernatant with KOH/KHCO 3 and the neutralized solution was applied to HPLC (Fig. 4a) . In order to identify radioactive material excreted from cells into the medium (see Fig. 4 b) the following procedure was adopted to prepare samples for application to HPLC. Three ml medium (total medium from a 5 cm diam. dish) were extracted with 2 ml ice-cold 0.5 M-perchloric acid. The precipitate which formed was removed by centrifugation at 2000 rev/min for 5 min (MSE 4L centrifuge). The supernatant was neutralized with 0.72 M-KOH/0.6 M-KHCO 3 (about 200 ~tl) at 0 °C. After 5 min, the precipitated KC104 was removed by centrifugation at 2000 rev/min for 10 min. The neutralized supernatant (about 4.5 ml) was then applied to a Bio-Rad AG l-X8 column (1 x 10 cm) and eluted with about 40 ml 0.05 M-sodium formate buffer pH 7. Fractions containing radioactivity were pooled, freeze-dried and applied to HPLC after dissolving them in 0.01 M-KH2PO 4 pH 5.5. These procedures were necessary to diminish the content of ions derived from the growth medium which would otherwise adversely affect the subsequent HPLC. Recovery of radioactivity from these Bio-Rad columns was greater than 90% and control experiments showed that no phosphorylated derivatives were present in the applied sample; after eluting thymidine with 0.05 ra-sodium formate, columns were routinely washed with 1 M-sodium formate which quantitatively eluted phosphorylated thymidine nueleotides, and radioactivity in these washes was negligible.
High
Purification of HS V-induced DNA-dependent DNA polymerase. Procedures used to purify the polymerase were based on the method of Powell & Purifoy (1977) (see Wallace et al., 1980) .
Kinetics of deoxyribonucleoside triphosphate utilization by the virus-induced DNA polymerase.
The assay when dTTP was the limiting substrate contained, in a final vol. of 200 ~1, 100 mM-tris-HCl pH 8.5 at 37 °C, 5 mM-dithiothreitol, 5 mM-MgC12, 100 mM-KC1, 0.26 mu each of dATP, dCTP, dGTP and 20 gg activated salmon sperm DNA. The [3H]dTTP concentration varied from 0.625 to 100 #M (5 Ci/mmol). When dGTP was the limiting substrate the assay contained 0.26 mM each of dCTP, dATP and dTTP with the [3H]dGTP concentration (5 Ci/mmol) varying between 0.05 and 50 gu. Assays were stopped by adding an equal volume of ice-cold 10% (w/v) trichloroacetic acid and the insoluble material was collected on filter discs and counted for radioactivity (Pearson et al., 1976) .
RESULTS
Rate of thymidine uptake, phosphorylation and incorporation into DNA throughout HSV-1 infection in the presence and absence of phosphonoacetate
Cells were treated with 5-FU before infecting them with virus in order to suppress host cell DNA synthesis (Kaplan & Ben-Porat, 1964) . Caesium chloride density gradient centrifugation experiments showed that this procedure inhibited host cell DNA synthesis by more than 90 % (results not shown), the little remaining DNA synthesis occurring only early in the infection cycle (see Fig. 1 ). This 5-FU pretreatment did not affect virus DNA synthesis during subsequent infection and incubation in medium without the drug.
After infection, entry of thymidine into cells was rapid, 30% of it being present in a phosphorylated form as determined by the ability to bind to DE-81 paper (Fig. 1) . The rates of thymidine uptake and phosphorylation increased rapidly to reach maximum values about 6 h after infection. Direct assays of thymidine kinase (by the method of Bittlingmaier et al., 1977) on cell lysates also showed a peak of activity about 6 h after infection. These events occurred to about equal extents both in the presence and absence of phosphonoacetate, the inhibitor of the virus-induced DNA polymerase, although both the rate of thymidine uptake and phosphorylation declined after 6 h in the presence of the inhibitor (Fig. 1 c, b) . Virus DNA synthesis was almost completely abolished by 6 h in the presence of this drug; in its absence the rate of DNA synthesis increased from 6 h post-infection to reach a maximum at 15 h (Fig. 1 a) . Little thymidine uptake was observed in mock-infected cells. In fact, total intracellular radioactivity was only about 1 to 5 % of the acid-soluble radioactivity present in virus-infected cells.
Total thymidine uptake, phosphorylation and incorporation into DNA throughout HSV-1 infection
In these experiments thymidine was present at 40 ~M, approximately equivalent to the intracellular thymidine nucleotide concentration after HSV infection of BHK cells (Jamieson & Bjursell, 1976a; see Discussion) . This was to facilitate the saturation of the intracellular pools by the salvage pathway and thereby perhaps more readily observe an effect on thymidine metabolism when DNA synthesis was prevented; for example, by feedback inhibition of thymidine phosphorylation and transport and/or by the occurrence of thymidine nucleotide degradation and excretion from the cell.
The accumulated thymidine transported into the cell and phosphorylated derivatives both reached maximum levels about 9 h after infection (Fig. 2c, b) . In the absence of phosphonoacetate these levels then decreased, presumably as a result of virus DNA synthesis, but when the drug was present there was only a small decrease in the radioactive acid-soluble pool. The large decrease at 30 h is probably a result of cell death at this time. The small amount of DNA synthesis (Fig. 2a) in the phosphonoacetate experiment was due to residual host cell synthesis which took place early in infection before the drug was present (see Fig. 1 a) . The observation (Fig. 2 c, b) that the accumulated radioactive acid-soluble pool remained at a relatively constant level throughout infection (between 9 and 24 h) when phosphonoacetate was present suggested to us, in view of the fact that thymidine is still transported into the cells and is phosphorylated during this time (Fig. 1 c, b) , that there must be an equivalent loss of radioactivity from the ceils (see the recent results of Taheri et al., 1981 where thymidine nucleotide-derived products are reportedly excreted from human lymphocytes). In order to investigate this putative degradation and excretion, we have determined the fate of thymidine nucleotides in isotopically labelled host cell DNA, since this is partially degraded [3H]thymidine (2.5 #Ci/ml) and then for a further 16 h after replacing the medium with fresh medium containing 5-fluorouracil (20/zg/ml) and [3H]thymidine (2.5/~Ci/ml). The cells were then infected with HSV-1 and incubated in the presence or absence of phosphonoacetate at 150 #g/ml. Samples were removed at various times and separated into cells and medium. The medium was retained for determination of excretion products and the cells were precipitated with perchloric acid; the supernatant from this precipitation step contained the intracellular acid-soluble radioactivity (see Methods). (a) Intracellular acid-precipitable radioactivity; (b) total intracellular acid-soluble radioactivity; (c) total radioactivity excreted into the medium (greater than 90% acid-soluble). O, Infected cells without phosphonoacetate; O, infected cells with phosphonoacetate. Values are the means _+ standard deviation (n = 4).
during HSV infection and we could thus be certain that any radioactivity appearing in the medium originated from inside the cells. We have also investigated directly the extent of excretion of radioactive molecules derived initially from thymidine transported into the cells from the medium (as suggested by results shown in Fig. 2) .
Effect of phosphonoacetate on the fate of host cell DNA in virus-injected cells
Over the duration of the experiment (24 h) the cellular content of host cell acid-precipitable DNA, which was radiolabelled with [3H]thymidine prior to infection, was diminished by about 50% (Fig. 3a) ; much of this was excreted from cells into the culture medium with about 30% being retained intracellularly as acid-soluble radioactivity (Fig. 3) . After 12 h of virus infection a plateau level of intracellular acid-soluble radioactivity was reached, although both DNA degradation and excretion of products into the medium continued. The only observable effect of phosphonoacetate was to produce a slightly greater level of intracellular acid-soluble radioactive material after 12 h. The appearance of radioactivity in the medium was not due to cell death since the cell number and cell viability, estimated by ability to exclude trypan blue, were decreased by only 1 to 2 % during the 24 h period.
Thymidine metabolism in HS V-l-injected cells
HPLC analysis of the acid-soluble degradation products revealed that the intracellular radioactivity was found exclusively in phosphorylated thymidine derivatives (Fig. 4a) , whereas the excreted radioactive molecules were identified as thymidine (Fig. 4 b) . We did not detect any further breakdown products of thymidine, such as thymine, dihydrothymine, fl-ureidoisobutyric acid or fl-aminoisobutyric acid. Presumably, the final dephosphorylation step is a plasma membrane-associated event since no intraceUular thymidine was observed, unless this was excreted too rapidly to be detected by our procedures. Control experiments in which dTTP was incubated with growth medium for 12 or 24 h showed a maximum conversion to thymidine of 20%, supporting our conclusions from the cell number and viability measurements that the radioactivity in the medium was excreted from the cells and did not result from leakage from dead or dying cells.
Since the loss of intracellular radioactivity could be mostly accounted for by radioactivity excreted as thymidine into the medium this suggests that the host DNA degradation products were not re-utifized for virus DNA synthesis. When cell lysates, taken at 2, 10 and 24 h after infection, were centrifuged to equilibrium in CsCI gradients only a single symmetrical peak of radioactivity was obtained banding with a buoyant density of host cell DNA (not shown). The fate of the host cell DNA appeared to be unaffected by the external thymidine concentration, since similar results were obtained when this was maintained at 0 or 40 gM throughout virus infection. In mock-infected cells the extent of host cell DNA degradation was consistently less than in virus-infected cells; acid-insoluble radioactivity was diminished by a maximum of about 25% at 26 h post-mock infection compared with the 50% degradation usually observed during virus infection. 
Excretion of intracellular radioactive molecules derived directly Jrom thymidine in the growth medium.
Since the experiments described above showed that excretion was a mechanism for removing unwanted thymidine derivatives from cells we were then able to confirm our original supposition, based on results shown in Fig. 2(b, c) , that excretion of molecules derived directly from the growth medium might also occur. In the experiment shown in Fig. 5 cells were incubated with [3H]thymidine for 8 h and then transferred to thymidine-free medium. The figure shows the acid-insoluble and intracellular acid-soluble radioactivity and also the appearance of radioactivity in the medium throughout infection. Fig. 5 (a) confirms that virus DNA synthesis had taken place in the absence but not in the presence of phosphonoacetate. Fig. 5 (b) shows initial high levels of intracellular acid-soluble radioactivity which decrease considerably both in the presence and absence of phosphonoacetate, but for different reasons. Thus, Fig. 5 (c) clearly shows that the intracellular acid-soluble molecules are excreted when DNA synthesis is prevented with phosphonoacetate but no such excretion occurs normally, i.e. when virus DNA synthesis is allowed to take place (at least not under our experimental conditions of low external thymidine concentration: about 0.05 /~M provided by the [3H]thymidine). The decrease in acid-soluble radioactivity shown in Fig. 5 (b) in the absence of phosphonoacetate is presumably due, therefore, to utilization of the thymidine nucleotides for virus DNA synthesis.
Kinetics of deoxyribonucleoside triphosphate utilization by the purified HS V-induced DNA polymerase
When dTTP was the limiting substrate we observed a biphasic double-reciprocal plot, previously unreported for this polymerase, from which two K m values of 0.5 and 5/~M were obtained with corresponding Vma X values of 208 and 370 nmol dTTP incorporated per 10 min (Fig. 6) . When dGTP was used as the limiting substrate, however, we observed a single linear plot which gave a K m value of 0.8/~M with a Vmax of 330 nmol of dGTP incorporated in the 10 min assay (not shown), g m values obtained in four different experiments were each within 5 °/6 of those quoted.
DISCUSSION
In view of the importance of thymidine nudeotides, both as precursors for DNA synthesis and as possible regulatory molecules of DNA precursor synthetic pathways, we have examined the fate of radiolabelled thymidine in cells in which virus DNA synthesis was prevented by inhibition of the virus-induced DNA polymerase and have carried out simple kinetic studies which support the concept of a broader role for thymidine nucleotides other than that as substrate for DNA synthesis.
Thymidine levels in the cell are maintained either by de novo synthesis or by the salvage pathway. It is clear from our studies, and the work of others (Jamieson & Bjursell, 1976a; Bittlingmaier et al., 1977) , that HSV-1 induces a massive uptake of exogenous thymidine by the salvage pathway into infected cells. Much of this (30 to 50%, see Fig. 1 and 2 ) is phosphorylated, presumably by the virus-induced thymidine kinase. In control infected cell cultures the rate of thymidine uptake and phosphorylation reached maximum levels at 6 h and remained approximately constant throughout the remaining 18 h. When the virus DNA synthesis was inhibited with phosphonoacetate, however, the rates of both of these processes declined, after 6 h, by up to 50% of the maximum value 24 h after infection (Fig. 1 b, e) . Cell number and viability were constant throughout this time. It appears from this, therefore, that there is some regulation in the uptake and phosphorylation of thymidine when DNA synthesis is prevented with phosphonoacetate. Control experiments showed that phosphonoacetate had no direct inhibitory effect on thymidine kinase in lysates from infected cells, suggesting that thymidine transport may be a primary site of regulation.
Experiments in which accumulated cellular radioactivity was measured (Fig. 2) suggested that excretion of thymine-containing molecules might occur and this was confirmed initially by studying the fate of the host cell DNA (Fig. 3) . These results were surprising since phosphonoacetate had no observable effect on the proportion of the degraded host cell DNA that was excreted into the medium as thymidine, i.e. about 60 to 70 % of the degraded (now acid-soluble) radioactive material (Fig. 3 e) . (The true relative proportion of thymidine nucleotides actually excreted would of course depend upon the extent to which these radioactive molecules were mixed with other endogenous molecules also destined for excretion.) It was anticipitated that in the absence of phosphonoacetate some of the thymidine nucleotides derived from the host DNA would have been utilized via the salvage pathway as precursors for virus DNA synthesis. Thus, the small difference in the intracellular radioactive acid-soluble pool after 12 h of infection (Fig. 3b) in the presence and absence of phosphonoacetate might be considered to represent that portion which was utilized for virus DNA synthesis. Even so, this shows that of the thymidine nucleotides produced from host cell DNA degradation only 5 to 10% could have been utilized for DNA synthesis. Our tentative interpretation of this is that the products of host cell DNA degradation may not be directly available to the pool of nucleotides that are utilized for virus DNA synthesis, although it seems probable that once excreted they could be taken back into the cells and utilized via the salvage pathway. However, our experiments with CsC1 density gradient centrifugation did not provide evidence of the incorporation of radioactive molecules into HSV DNA.
The importance of thymidine nucleotides in nucleic acid metabolism in normal, transformed and virus-infected cells has already been emphasized (Bjursell et al., 1972; Jamieson & Bjursell, 1976a, b; Ponce de Leon et al., 1977) . More recently, TaylorPapadimitriou & Rozengurt (1979) demonstrated a severe depression of cell proliferation in cells of bovine or murine origin when thymidine transport was inhibited with s-(pnitrobenzyl)-6-mercaptoinosine and thus drew attention to the importance of the salvage pathway for thymidine in multicellular organisms. Jamieson & Bjursell (1976a, b) argued that the 20-fold increase in dTTP pools during HSV infection of BHK cells was more than the virus required for the synthesis of DNA, particularly in view of the high G + C content of the virus genome, and suggested that it played an additional role in nucleotide metabolism. Our observations on the kinetics of dTTP utilization by the purified herpesvirus-induced DNA polymerase suggest that, in addition to this, dTTP may regulate its own utilization as a substrate for DNA synthesis.
When dGTP was the limiting substrate we observed classical Michaelis Menten kinetics from which a K m value of 0.8/~M was obtained. This agrees closely with values reported by Furman et al. (1979) when dGTP was used as substrate for DNA polymerase from four different strains of HSV-1, although it is somewhat greater than the value reported recently by Ostrander & Cheng (1980) . When dTTP was the limiting substrate, however, we observed biphasic kinetics showing substrate activation occurring at the higher substrate concentrations used (Fig. 6) , although the K m value increased from 0.5 to 5 /~M. Ostrander & Cheng (1980) reported only a single K m value of 0.14/~M for dTTP for the HSV-l-induced DNA polymerase. The different kinetic behaviour observed by these workers, compared with our results, possibly reflects differences in the purity of the polymerases and in the conditions of the assays. Our results suggest that the affinity of the polymerase is highest when the dTTP concentration is low, early in infection, and decreases later in infection when the dTTP concentration increases markedly. They also support the hypothesis that a certain minimum concentration of dTTP is required before DNA synthesis can occur, since at the lower dTTP concentrations used the observed Vma x was relatively low, being 208 nmol dTTP incorporated per 10 rain compared with 370 nmol incorporated when higher concentrations were used.
Using BHK cell volumes reported by McDonald et al. (1972) , and assuming equal distribution of dTTP throughout the cell, calculations of the dTTP concentration in our HSV-infected cells can be made. The concentration in resting, uninfected BHK cells is about 2 to 4 #M and after infection with HSV-I would rise to between 30 and 70/~M (these latter values would be higher after infection of exponentially growing cells; see Jamieson & Bjursell, 1976a) . The change in slope on our double-reciprocal plot (Fig. 6 ) occurs at about 5 /~M-dTTP, thus supporting the above suggestion that the polymerase has highest affinity for this substrate when the cellular concentration is low, before the virus-induced thymidine kinase activity can increase the pool size. Non-hyperbolic DNA polymerase kinetics have previously been reported for the unicellular green flagellate Euglena graeilis (McLennan & Keir, 1975) . The stimulation of polymerases A and B (authors' nomenclature), which occurred at high concentrations of deoxyribonucleoside triphosphates, was attributed to substrate activation, and allosteric control of the enzymes was considered as a possible reason for this.
In summary our results show that (1) the inhibition of virus DNA synthesis does not result in a change in the initial rates of thymidine transport and phosphorylation, although these rates are subsequently diminished by up to 50% of the maximum rates late in infection, (2) much of the host cell DNA is degraded and the products excreted as a result of virus infection suggesting (i) that these nucleotides are not directly available as precursors for virus DNA synthesis and (ii) degradation and excretion of nucleotide derivatives may be an important contributory mechanism for regulating the intracellular nucleotide pool concentrations and (3) dTTP may possibly regulate its own utilization by DNA polymerase in addition to the many other regulatory functions assigned to it. H.N.B. was in receipt of an SRC studentship and B. A. Murray an MRC studentship. We also acknowledge support provided by Medical Endowments, University of Aberdeen. We thank Professor H. M. Keir for his interest and encouragement.
